Nortriptyline 20mg Taper Schedule
For nortriptyline 20mg, reduce the dose by 10% of the current dose every 4-6 weeks, which translates to approximately 2mg reductions initially, with progressively smaller decrements as you approach discontinuation. This hyperbolic tapering approach minimizes withdrawal symptoms by maintaining consistent changes in receptor occupancy throughout the taper 1, 2.
Specific Tapering Protocol
Initial Considerations
Before starting the taper, the FDA label emphasizes that discontinuation should occur gradually when possible, though specific schedules are not mandated 3. The drug should be discontinued promptly only if serious adverse effects occur 3.
Recommended Schedule
Week 0-4: Reduce from 20mg to 18mg daily
- This represents a 10% reduction from baseline
- Monitor for withdrawal symptoms or symptom recurrence
Week 4-10: Reduce from 18mg to 16mg daily
- Continue 10% reductions every 4-6 weeks
- Adjust timing based on patient tolerance
Week 10-16: Reduce from 16mg to 14mg daily
Week 16-22: Reduce from 14mg to 12mg daily
Week 22-28: Reduce from 12mg to 10mg daily
As doses decrease below 10mg, slow the taper further:
- 10mg → 9mg → 8mg → 7mg → 6mg → 5mg → 4mg → 3mg → 2mg → 1mg → 0.5mg → discontinue
- Each reduction should occur every 6-8 weeks or longer if withdrawal symptoms emerge
- Final reductions may need to be as small as 0.5mg or less 2, 4
Critical Implementation Points
Formulation Strategies
Since nortriptyline comes as an oral solution 3, this allows for precise dose reductions at lower doses. For very small final doses (below 5mg), the liquid formulation becomes essential to achieve the tiny decrements needed 1, 2.
Monitoring Requirements
- Evaluate at each dose reduction for withdrawal symptoms (anxiety, insomnia, gastrointestinal distress, mood changes) 5
- Check-ins every 2-4 weeks during active tapering, using telehealth if needed 2
- Monitor for 2-4 weeks after complete discontinuation for protracted withdrawal symptoms 2
Adjusting the Taper
If withdrawal symptoms emerge:
- Pause at current dose until symptoms stabilize (typically 2-4 weeks)
- Consider smaller reductions (5% instead of 10%)
- Slow the pace to every 8-12 weeks between reductions
- Only return to previous dose if symptoms are intolerable despite these adjustments 2
If approaching discontinuation becomes difficult:
- The final steps are often the hardest pharmacologically 4
- Proactively slow to 5% reductions or smaller
- Extend intervals to 8-12 weeks between final reductions
- The last dose before zero should not exceed 0.5-1mg to avoid a large pharmacological "jump" 4
Common Pitfalls to Avoid
Never use alternate-day dosing as a tapering strategy. Skipping days creates large fluctuations in drug levels and receptor occupancy, significantly increasing withdrawal risk 6.
Avoid linear reductions (e.g., reducing by 5mg every month). This creates increasingly large pharmacological effects as the dose decreases, making the taper progressively more difficult 4.
Do not rush elderly patients. The FDA specifically notes that elderly patients require lower doses and may have higher concentrations of active metabolites 3. They may need even slower tapers (5% reductions every 8-12 weeks).
Special Populations
Elderly Patients
Given that plasma concentrations and active metabolite levels are higher in elderly patients 3, use the conservative end of tapering recommendations:
- 5% reductions every 8-12 weeks
- More frequent monitoring for confusion or cardiovascular effects
- Consider starting taper from an even lower maintenance dose if possible
Duration Considerations
Total taper duration: Expect 6-12 months minimum for a 20mg dose, potentially extending to 18-24 months if withdrawal symptoms require slower tapering 2. This extended timeline is appropriate and evidence-based—rushing increases failure rates and patient distress.